Polyclonal Rabbit anti‑Human TPC2 / TPCN2 Antibody (N‑Terminus, IHC, WB) LS‑C178859
Polyclonal Rabbit anti‑Human TPC2 / TPCN2 Antibody (N‑Terminus, IHC, WB) LS‑C178859
Antibody:
TPC2 / TPCN2 Rabbit anti-Human Polyclonal (N-Terminus) Antibody
Application:
IHC, WB, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
TPC2 / TPCN2 Rabbit anti-Human Polyclonal (N-Terminus) Antibody
Application:
IHC, WB, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
TPCN2 antibody LS-C178859 is an unconjugated rabbit polyclonal antibody to human TPCN2 (TPC2) (N-Terminus). Validated for ELISA, IHC and WB.
Target
Human TPC2 / TPCN2
Synonyms
TPCN2 | TPC2 | Two pore segment channel 2 | SHEP10
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Affinity purified
Immunogen
A peptide from N-Terminus residues of human TPCN2 protein.
Specificity
Human TPC2 / TPCN2.
Applications
- IHC (1:100 - 1:500)
- Western blot (1:500 - 1:1000)
- ELISA (1:20000 - 1:80000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
PBS, pH 7.4, 0.02% Sodium Azide
Storage
Store at -20°C for up to 1 year.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human
Applications:
ICC, Immunofluorescence, Peptide Enzyme-Linked Immunosorbent Assay
Reactivity:
Human
Range:
0.31-20 ng/ml
Species:
Human
Applications:
Flow Cytometry, Functional Assay
Species:
Cow, Human, Mouse, Bovine, Pig
Applications:
Western blot
Reactivity:
Mouse
Range:
6.25-400 pg/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 9/19/2024